SERNF yields 2.29% · PFE yields 6.13%● Live data
📍 SERNF pulled ahead of the other in Year 1
Combined, SERNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SERNF + PFE for your $10,000?
Seiren Co.,Ltd. plans, manufactures, and markets textile and chemical products, industrial machines, and electronic parts in Japan and internationally. The company operates through Automotive Upholstery Materials, Electronics Materials, High Fashion Materials, Environmental & Life Materials, and Medical Materials segments. The Automotive Upholstery Materials segment offers car seat cover, instrument panel (decorative), and airbag materials. The Electronics Materials segment provides electrically conductive and high-performance wiping cloth materials, high-strength yarns, and precision devices. The Environmental & Life Materials segment offers house exterior wall covering moisture-permeable waterproof sheet materials, office interior materials, civil engineering materials, and nursing care-related materials. The High Fashion Materials segment offers fashion clothing, sports outdoor clothing, and inner clothing materials. The Medical Materials segment provides cosmetics/pharmaceutical related, medical care, and nursing care materials. It also offers digital production systems; and civil engineering, construction, interior, and industrial materials The company was formerly known as Fukui Seiren Kako Co., Ltd. and changed its name to Seiren Co.,Ltd. in 1973. Seiren Co.,Ltd. was founded in 1889 and is headquartered in Tokyo, Japan.
Full SERNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.